Europe (WHO region) vs Trinidad and Tobago: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Europe (WHO region)
89.0%
in 2025
Trinidad and Tobago
99.0%
in 2025
Europe (WHO region) rank
2nd
Trinidad and Tobago rank
1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Europe (WHO region)
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Trinidad and Tobago's figure about 1.1 times Europe (WHO region)'s.
Across all 5 years both countries report, Trinidad and Tobago has been ahead every year.
Europe (WHO region) ranks 2nd and Trinidad and Tobago ranks 1st of 11 groups.
Trinidad and Tobago has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Europe (WHO region) or Trinidad and Tobago?
- Trinidad and Tobago, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Europe (WHO region) and Trinidad and Tobago?
- 10.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Europe (WHO region) and Trinidad and Tobago?
- 5 years are reported by both, from 2021 to 2025.
- How do Europe (WHO region) and Trinidad and Tobago rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Europe (WHO region) ranks 2nd and Trinidad and Tobago ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.